ArticleAdvances in therapy2025

Long-Term Experience with Luspatercept in Relapsed/Refractory Myelodysplastic Neoplasms: A Chinese Real-World Study.

Zhuxin Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.